HopeStage
Back to all studies
CompletedNCT06309472

Mirtazapine study for depression with inflammatory bowel disease

About this titleRead the official source — NCT06309472
Medication studyAges 18–125United Kingdom
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 125 years. Other eligibility criteria applied.

What did participation involve?

The protocol includes: Completing questionnaires. Providing blood samples.

Listed locations
London and 3 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 7, 2024
Recruitment status
Completed
Enrollment listed in the registry
76
Sponsor
King's College London
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
From 18 Years to 125 Years
Official registry ID
NCT06309472
Official title
Show the full official title

A Multi-centre, Double-blind Randomised Controlled Trial to Compare Mirtazapine Versus Placebo Over 12 Weeks in Patients With Multimorbid Major Depression and Inflammatory Bowel Disease (MD-IBD): a Feasibility Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did participation involve?

The protocol called for participants to provide blood samples.

Who is behind this study?

The study sponsor is King's College London, a university.

Did this study involve medication?

Yes. The study involved medication, including Mirtazapine and Placebo.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 125 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies